The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
that 2011 shift into understanding that there's mci and that even before that preclinical alzheimer's allowed us to then design trials that are currently ongoing looking at both prevention by amyloid removal before cognitive symptoms start and then also treating people with mild cognitive impairment who do have some symptoms of memory loss but are not yet demented because they're so functional in their day-to-day
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.